×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Arcutis Biotherapeutics Inc. (ARQT) NASDAQ

$8.54 0.26 (3.14%)

Market Cap: $958.53M

As of 06/21/24 10:56 AM EDT. Market open.

(ARQT)

Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ

$8.54
0.26 (3.14%)

Market Cap: $958.53M

As of 06/21/24 10:56 AM EDT. Market open.

Add to Portfolio

arcutis biotherapeutics, inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. its lead product candidate is arq-151, a topical cream formulation of roflumilast that is in phase iii clinical trials for the treatment of plaque psoriasis and atopic dermatitis. the company is also developing arq-154, a topical foam formulation of arq-151 ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
269
Address
.
PRICE CHART FOR ARCUTIS BIOTHERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.36
Previous Close
$8.28
Days Range
$7.89 - $8.47
52 week range
$1.76 - $13.17
Volume
401,990
Avg. Volume (30 days)
2,494,850
Market Cap
$958.53M
Dividend Yield
-
P/E
(4.41)
Shares Outstanding
115,764,164
Open
$8.36
Previous Close
$8.28
Days Range
$7.89 - $8.47
52 week range
$1.76 - $13.17
Volume
401,990
Avg. Volume (30 days)
2,494,850
Market Cap
$958.53M
Dividend Yield
-
P/E
(4.41)
Shares Outstanding
115,764,164
FINANCIAL STATEMENTS FOR ARCUTIS BIOTHERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ARCUTIS BIOTHERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Welgus Howard G.DirectorJun 04, 2024 Option Exercise$1.6810,00016,806180,200Jun 06, 2024, 04:15 PM
Welgus Howard G.DirectorJun 04, 2024 Sale$8.0110,00080,092176,658Jun 06, 2024, 04:15 PM
Burnett PatrickSee RemarksMay 30, 2024 Sale$8.7523,000201,319209,793May 31, 2024, 04:50 PM
Burnett PatrickSee RemarksMay 29, 2024 Sale$8.7249,952435,387209,793May 31, 2024, 04:50 PM
Matsuda MasaruSee RemarkMay 28, 2024 Sale$9.011,77515,988188,508May 29, 2024, 07:38 PM
Edwards Larry ToddSVP Chief Commercial OfficerMay 17, 2024 Sale$8.987,64068,582140,360May 20, 2024, 05:12 PM
Moore Matthew RichardSVP and Chief Business OfficerMay 02, 2024 Sale$8.744,68140,902145,505May 03, 2024, 04:29 PM
Watanabe Todd FranklinSee RemarksMay 02, 2024 Sale$8.7413,783120,433860,750May 03, 2024, 04:22 PM
Matsuda MasaruSee RemarkMay 02, 2024 Sale$8.745,01643,829185,408May 03, 2024, 04:22 PM
Burnett PatrickSee RemarksMay 02, 2024 Sale$8.749,55583,490259,745May 03, 2024, 04:22 PM
Matsuda MasaruSee RemarkMar 04, 2024 Sale$11.123,76041,816190,424Mar 06, 2024, 05:14 PM
Burnett PatrickSee RemarksMar 04, 2024 Sale$11.124,78253,182269,300Mar 06, 2024, 05:12 PM
Watanabe Todd FranklinSee RemarksMar 04, 2024 Sale$11.1214,903165,739874,533Mar 06, 2024, 05:09 PM
Moore Matthew RichardSVP and Chief Business OfficerMar 04, 2024 Sale$11.123,46838,568146,020Mar 06, 2024, 05:08 PM
Heron Patrick JDirectorMar 04, 2024 Buy$9.5021,052199,9948,785,284Mar 06, 2024, 04:28 PM
Burnett PatrickSee RemarksJan 02, 2024 Sale$3.541,3254,69257,032Jan 03, 2024, 05:30 PM
Watanabe Todd FranklinSee RemarksDec 01, 2023 Option Exercise$1.6859,525100,038513,682Dec 01, 2023, 08:51 PM
Watanabe Todd FranklinSee RemarksMay 31, 2023 Buy$6.381,4639,334515,145Dec 01, 2023, 08:51 PM
Matsuda MasaruSee RemarkNov 21, 2023 Sale$1.981,8503,66146,634Nov 21, 2023, 05:47 PM
Frazier Life Sciences VIII, L.P.10% OwnerOct 24, 2023 Buy$2.5080,000200,0008,764,232Oct 26, 2023, 04:09 PM
Burnett PatrickSee RemarksAug 21, 2023 Sale$7.041,60511,30259,662Aug 22, 2023, 12:24 PM
Matsuda MasaruSee RemarkMay 31, 2023 Option Exercise$6.381,4639,33443,609Jun 02, 2023, 08:31 PM
Matsuda MasaruSee RemarkMay 31, 2023 Sale$7.801,83014,27842,146Jun 02, 2023, 08:31 PM
Welgus Howard G.DirectorApr 17, 2023 Option Exercise$1.688,50014,285174,325Apr 18, 2023, 07:00 PM
Welgus Howard G.DirectorApr 17, 2023 Sale$13.978,500118,728165,825Apr 18, 2023, 07:00 PM
Welgus Howard G.DirectorApr 06, 2023 Option Exercise$1.688,50014,285174,325Apr 10, 2023, 04:13 PM
Welgus Howard G.DirectorApr 06, 2023 Sale$12.018,500102,085165,825Apr 10, 2023, 04:13 PM
Watanabe Todd FranklinSee RemarksMar 06, 2023 Sale$15.262,43537,167366,657Mar 08, 2023, 04:29 PM
Burrows Scott LChief Financial OfficerMar 06, 2023 Sale$15.262914,44259,115Mar 08, 2023, 04:29 PM
Burnett PatrickSee RemarksMar 06, 2023 Sale$15.2685112,98959,962Mar 08, 2023, 04:28 PM
Turney Patricia A.SVP, OperationsMar 06, 2023 Sale$15.2683112,68462,862Mar 08, 2023, 04:26 PM
OSBORNE DAVID WChief Technical OfficerMar 06, 2023 Sale$15.2669010,532268,854Mar 08, 2023, 04:26 PM
Lock Kenneth A.Chief Commercial OfficerMar 06, 2023 Sale$15.2683112,68463,429Mar 08, 2023, 04:25 PM
Moore Matthew RichardSee RemarksMar 02, 2023 Sale$15.831,61025,48111,711Mar 06, 2023, 06:54 PM
Matsuda MasaruSee RemarksMar 02, 2023 Sale$15.831,43422,69618,119Mar 06, 2023, 06:52 PM
Burnett PatrickSee RemarksMar 02, 2023 Sale$15.831,75127,71339,836Mar 06, 2023, 06:51 PM
Turney Patricia A.SVP, OperationsFeb 28, 2023 Sale$16.1793615,13247,125Mar 02, 2023, 07:07 PM
Turney Patricia A.SVP, OperationsMar 02, 2023 Sale$15.831,43222,66445,711Mar 02, 2023, 07:07 PM
Watanabe Todd FranklinSee RemarksMar 02, 2023 Sale$15.835,47286,606369,161Mar 02, 2023, 07:06 PM
Watanabe Todd FranklinSee RemarksFeb 28, 2023 Sale$16.172,34337,878374,564Mar 02, 2023, 07:06 PM
Burrows Scott LChief Financial OfficerMar 02, 2023 Sale$15.831,43422,69638,424Mar 02, 2023, 07:05 PM
Burrows Scott LChief Financial OfficerFeb 28, 2023 Sale$16.174166,72539,840Mar 02, 2023, 07:05 PM
Lock Kenneth A.Chief Commercial OfficerMar 02, 2023 Sale$15.831,43222,66443,278Mar 02, 2023, 07:04 PM
Lock Kenneth A.Chief Commercial OfficerFeb 28, 2023 Sale$16.1793615,13244,692Mar 02, 2023, 07:04 PM
OSBORNE DAVID WChief Technical OfficerMar 02, 2023 Sale$15.831,21319,198254,659Mar 02, 2023, 07:03 PM
OSBORNE DAVID WChief Technical OfficerFeb 28, 2023 Sale$16.1779212,804255,857Mar 02, 2023, 07:03 PM
Welgus Howard G.DirectorFeb 15, 2023 Option Exercise$1.688,50014,285174,325Feb 21, 2023, 07:20 AM
Welgus Howard G.DirectorFeb 15, 2023 Sale$16.988,500144,352165,825Feb 21, 2023, 07:20 AM
Watanabe Todd FranklinSee RemarksFeb 14, 2023 Sale$17.025178,800377,007Feb 15, 2023, 07:09 PM
Watanabe Todd FranklinSee RemarksFeb 13, 2023 Sale$17.004838,211377,466Feb 15, 2023, 07:09 PM
Watanabe Todd FranklinSee RemarksFeb 01, 2023 Sale$17.001,00017,003378,289Feb 03, 2023, 04:26 PM
Welgus Howard G.DirectorJan 17, 2023 Option Exercise$1.688,50014,280174,325Jan 18, 2023, 08:18 PM
Welgus Howard G.DirectorJan 17, 2023 Sale$13.728,500116,655165,825Jan 18, 2023, 08:18 PM
Burnett PatrickSee RemarksJan 03, 2023 Sale$15.011,47522,13641,564Jan 04, 2023, 05:15 PM
Watanabe Todd FranklinSee RemarksDec 07, 2022 Sale$17.061,00017,060378,907Dec 09, 2022, 04:47 PM
Matsuda MasaruSee RemarkNov 21, 2022 Sale$18.191,72031,28919,535Nov 22, 2022, 07:06 PM
Welgus Howard G.DirectorNov 15, 2022 Option Exercise$1.681,0201,714169,228Nov 17, 2022, 04:29 PM
Welgus Howard G.DirectorNov 15, 2022 Sale$20.013,40368,103165,825Nov 17, 2022, 04:29 PM
Watanabe Todd FranklinSee RemarksNov 07, 2022 Sale$18.001,00018,004379,907Nov 09, 2022, 04:39 PM
Watanabe Todd FranklinPresident and CEOOct 07, 2022 Sale$19.511,00019,510380,907Oct 11, 2022, 06:47 PM
Welgus Howard G.DirectorOct 04, 2022 Sale$20.296,000121,766168,208Oct 06, 2022, 04:26 PM
Burrows Scott LChief Financial OfficerSep 16, 2022 Option Exercise$1.685,0008,40340,256Sep 20, 2022, 04:37 PM
Watanabe Todd FranklinPresident and CEOSep 07, 2022 Sale$21.511,00021,510381,907Sep 09, 2022, 05:10 PM
Welgus Howard G.DirectorAug 15, 2022 Sale$24.806,000148,789174,208Aug 17, 2022, 05:06 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2022 Option Exercise$1.682,5004,202654,371Aug 09, 2022, 05:16 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2022 Sale$24.742,50061,858651,871Aug 09, 2022, 05:16 PM
Frazier Life Sciences VIII, L.P.10% OwnerAug 05, 2022 Buy$20.00250,0005,000,0008,684,232Aug 09, 2022, 04:34 PM
Turney Patricia A.SVP, OperationsMar 23, 2022 Option Exercise$6.5215,33199,95846,444Aug 04, 2022, 08:42 PM
Welgus Howard G.DirectorJul 18, 2022 Sale$24.406,000146,374180,208Jul 18, 2022, 06:53 PM
OSBORNE DAVID WChief Technical OfficerJul 08, 2022 Sale$25.412,19755,835256,649Jul 12, 2022, 07:30 PM
Watanabe Todd FranklinPresident and CEOJul 08, 2022 Option Exercise$1.687,08711,910658,958Jul 12, 2022, 07:30 PM
Watanabe Todd FranklinPresident and CEOJul 08, 2022 Sale$25.3713,500342,473656,784Jul 12, 2022, 07:30 PM
Watanabe Todd FranklinPresident and CEOJul 06, 2022 Sale$22.071,00022,070658,284Jul 07, 2022, 04:04 PM
ORBIMED ADVISORS LLC10% OwnerJun 24, 2022 Sale$21.31341,9717,287,4023,534,537Jun 28, 2022, 04:29 PM
Watanabe Todd FranklinPresident and CEOJun 06, 2022 Sale$21.061,00021,064659,284Jun 06, 2022, 04:06 PM
Matsuda MasaruSVP and General CounselJun 02, 2022 Sale$19.731,79535,41916,380Jun 02, 2022, 04:48 PM
Welgus Howard G.DirectorJun 01, 2022 Option Exercise$1.682,5004,202184,396Jun 02, 2022, 04:48 PM
Welgus Howard G.DirectorJun 01, 2022 Sale$20.622,50051,539181,896Jun 02, 2022, 04:48 PM
Watanabe Todd FranklinPresident and CEOMay 05, 2022 Sale$21.761,00021,760658,667May 05, 2022, 05:31 PM
Welgus Howard G.DirectorMay 02, 2022 Option Exercise$1.022,5002,555184,396May 03, 2022, 05:14 PM
Welgus Howard G.DirectorMay 02, 2022 Sale$20.442,50051,112181,896May 03, 2022, 05:14 PM
OSBORNE DAVID WChief Technical OfficerApr 21, 2022 Sale$20.422,19744,872257,229Apr 21, 2022, 06:32 PM
ORBIMED ADVISORS LLC10% OwnerApr 07, 2022 Sale$20.66344,9967,127,6173,937,764Apr 08, 2022, 06:06 PM
ORBIMED ADVISORS LLC10% OwnerApr 06, 2022 Sale$20.69333,2046,893,9914,105,564Apr 08, 2022, 06:06 PM
ORBIMED ADVISORS LLC10% OwnerApr 08, 2022 Sale$20.71200,0004,142,0003,840,564Apr 08, 2022, 06:06 PM
Watanabe Todd FranklinPresident and CEOApr 05, 2022 Sale$21.431,00021,430659,667Apr 05, 2022, 06:45 PM
Welgus Howard G.DirectorApr 01, 2022 Option Exercise$0.587,5004,352189,396Apr 01, 2022, 04:55 PM
Welgus Howard G.DirectorApr 01, 2022 Sale$20.027,500150,184181,896Apr 01, 2022, 04:55 PM
Turney Patricia A.SVP, OperationsMar 23, 2022 Option Exercise$6.5225,328165,13956,441Mar 30, 2022, 08:02 PM
Turney Patricia A.SVP, OperationsMar 23, 2022 Option Exercise$6.5225,328165,13956,441Mar 25, 2022, 04:11 PM
Watanabe Todd FranklinPresident and CEOMar 09, 2022 Sale$17.003005,100660,667Mar 11, 2022, 09:42 PM
Watanabe Todd FranklinPresident and CEOMar 07, 2022 Option Exercise$1.687001,176661,667Mar 07, 2022, 08:59 PM
Watanabe Todd FranklinPresident and CEOMar 07, 2022 Sale$17.0577013,125660,967Mar 07, 2022, 08:59 PM
Watanabe Todd FranklinPresident and CEOMar 04, 2022 Sale$16.862,48941,962661,037Mar 07, 2022, 08:59 PM
Burnett PatrickSee RemarksMar 04, 2022 Sale$16.8698116,53943,069Mar 07, 2022, 08:53 PM
Burnett PatrickSee RemarksMar 07, 2022 Sale$16.443049343,039Mar 07, 2022, 08:53 PM
Lock Kenneth A.Chief Commercial OfficerMar 07, 2022 Sale$16.443049344,011Mar 07, 2022, 08:49 PM
Lock Kenneth A.Chief Commercial OfficerMar 04, 2022 Sale$16.8699316,74144,041Mar 07, 2022, 08:49 PM
Burrows Scott LChief Financial OfficerMar 07, 2022 Sale$16.441016435,256Mar 07, 2022, 08:49 PM
Burrows Scott LChief Financial OfficerMar 04, 2022 Sale$16.862934,94035,266Mar 07, 2022, 08:49 PM
Turney Patricia A.SVP, OperationsMar 07, 2022 Sale$16.443049331,113Mar 07, 2022, 08:48 PM
Turney Patricia A.SVP, OperationsMar 04, 2022 Sale$16.8699316,74131,143Mar 07, 2022, 08:48 PM
OSBORNE DAVID WChief Technical OfficerMar 07, 2022 Sale$16.4428460259,426Mar 07, 2022, 08:47 PM
OSBORNE DAVID WChief Technical OfficerMar 04, 2022 Sale$16.8682813,959259,454Mar 07, 2022, 08:47 PM
Watanabe Todd FranklinPresident and CEOMar 01, 2022 Sale$17.752,15338,222592,626Mar 03, 2022, 04:18 PM
Lock Kenneth A.Chief Commercial OfficerMar 01, 2022 Sale$17.7593516,59931,734Mar 03, 2022, 04:15 PM
Watanabe Todd FranklinPresident and CEOFeb 09, 2022 Option Exercise$1.681,0001,681595,779Feb 11, 2022, 05:55 PM
Watanabe Todd FranklinPresident and CEOFeb 09, 2022 Sale$17.001,00017,000594,779Feb 11, 2022, 05:55 PM
Watanabe Todd FranklinPresident and CEOJan 05, 2022 Option Exercise$1.681,0001,681595,779Jan 07, 2022, 04:17 PM
Watanabe Todd FranklinPresident and CEOJan 05, 2022 Sale$21.591,00021,592595,479Jan 07, 2022, 04:17 PM
Welgus Howard G.DirectorJan 03, 2022 Option Exercise$0.582,5001,451184,396Jan 05, 2022, 05:19 PM
Welgus Howard G.DirectorJan 03, 2022 Sale$21.212,50053,029181,896Jan 05, 2022, 05:19 PM
Burrows Scott LChief Financial OfficerDec 27, 2021 Sale$20.0712,560252,13922,679Dec 28, 2021, 05:00 PM
Welgus Howard G.DirectorDec 23, 2021 Option Exercise$0.582,5001,451184,396Dec 23, 2021, 09:46 PM
Welgus Howard G.DirectorDec 23, 2021 Sale$20.162,50050,395181,896Dec 23, 2021, 09:46 PM
Watanabe Todd FranklinPresident and CEODec 08, 2021 Option Exercise$1.681,0001,681595,779Dec 10, 2021, 06:41 PM
Watanabe Todd FranklinPresident and CEODec 08, 2021 Sale$17.001,00017,000594,779Dec 10, 2021, 06:41 PM
Watanabe Todd FranklinPresident and CEONov 05, 2021 Option Exercise$1.681,0001,681595,779Nov 09, 2021, 05:19 PM
Watanabe Todd FranklinPresident and CEONov 05, 2021 Sale$21.501,00021,502594,779Nov 09, 2021, 05:19 PM
Welgus Howard G.DirectorNov 01, 2021 Option Exercise$0.582,5001,451184,396Nov 03, 2021, 05:16 PM
Welgus Howard G.DirectorNov 01, 2021 Sale$21.812,50054,524181,896Nov 03, 2021, 05:16 PM
Watanabe Todd FranklinPresident and CEOOct 05, 2021 Option Exercise$1.682,5004,202597,279Oct 07, 2021, 04:05 PM
Watanabe Todd FranklinPresident and CEOOct 05, 2021 Sale$24.922,50062,294594,779Oct 07, 2021, 04:05 PM
Welgus Howard G.DirectorOct 01, 2021 Option Exercise$0.582,5001,451184,396Oct 05, 2021, 02:11 PM
Welgus Howard G.DirectorOct 01, 2021 Sale$23.872,50059,680181,896Oct 05, 2021, 02:11 PM
Watanabe Todd FranklinPresident and CEOOct 01, 2021 Option Exercise$1.681,5002,521596,279Oct 05, 2021, 02:10 PM
Watanabe Todd FranklinPresident and CEOOct 01, 2021 Sale$25.011,50037,510594,779Oct 05, 2021, 02:10 PM
Watanabe Todd FranklinPresident and CEOSep 07, 2021 Option Exercise$1.681,0001,681595,779Sep 09, 2021, 05:42 PM
Watanabe Todd FranklinPresident and CEOSep 07, 2021 Sale$21.141,00021,137594,779Sep 09, 2021, 05:42 PM
Welgus Howard G.DirectorSep 01, 2021 Option Exercise$1.565,0007,791186,896Sep 03, 2021, 05:07 PM
Welgus Howard G.DirectorSep 01, 2021 Sale$20.805,000103,986182,696Sep 03, 2021, 05:07 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2021 Option Exercise$1.681,0001,681595,779Aug 09, 2021, 06:51 PM
Watanabe Todd FranklinPresident and CEOAug 05, 2021 Sale$20.811,00020,810594,779Aug 09, 2021, 06:51 PM
Watanabe Todd FranklinPresident and CEOJul 06, 2021 Option Exercise$1.681,7502,941596,529Jul 08, 2021, 07:40 PM
Watanabe Todd FranklinPresident and CEOJul 06, 2021 Sale$26.581,75046,515594,779Jul 08, 2021, 07:40 PM
Welgus Howard G.DirectorJul 01, 2021 Option Exercise$3.942,2008,674184,096Jul 06, 2021, 07:14 PM
Welgus Howard G.DirectorJul 01, 2021 Sale$26.132,20057,476182,146Jul 06, 2021, 07:14 PM
CHAUDHURI BHASKARDirectorJun 24, 2021 Sale$27.5072920,048848,146Jun 28, 2021, 04:11 PM
CHAUDHURI BHASKARDirectorJun 25, 2021 Sale$27.506,755185,763841,391Jun 28, 2021, 04:11 PM
CHAUDHURI BHASKARDirectorJun 21, 2021 Sale$27.502,51669,190848,875Jun 23, 2021, 05:47 PM
Watanabe Todd FranklinPresident and CEOJun 07, 2021 Option Exercise$1.681,7502,941596,529Jun 09, 2021, 04:35 PM
Watanabe Todd FranklinPresident and CEOJun 07, 2021 Sale$26.351,75046,113594,779Jun 09, 2021, 04:35 PM
CHAUDHURI BHASKARDirectorApr 20, 2021 Sale$28.0610,000280,568862,671May 19, 2021, 06:43 PM
Watanabe Todd FranklinPresident and CEOMay 05, 2021 Option Exercise$1.681,6072,701595,523May 07, 2021, 11:29 AM
Watanabe Todd FranklinPresident and CEOMay 05, 2021 Sale$34.001,75059,500593,773May 07, 2021, 11:29 AM
Welgus Howard G.DirectorMay 03, 2021 Option Exercise$3.942,2008,674213,141May 05, 2021, 02:05 PM
Welgus Howard G.DirectorMay 03, 2021 Sale$34.792,20076,547211,858May 05, 2021, 02:05 PM
Watanabe Todd FranklinPresident and CEOApr 30, 2021 Sale$35.001,50052,500593,916May 04, 2021, 03:00 PM
CHAUDHURI BHASKARDirectorApr 20, 2021 Sale$28.0610,000280,568862,671Apr 22, 2021, 08:17 PM
Welgus Howard G.DirectorApr 16, 2021 Option Exercise$1.172,6553,117210,941Apr 20, 2021, 05:43 PM
CHAUDHURI BHASKARDirectorMar 22, 2021 Sale$31.1010,000311,021876,383Mar 24, 2021, 11:33 AM
Welgus Howard G.DirectorMar 16, 2021 Option Exercise$1.172,6533,114208,286Mar 18, 2021, 01:59 PM
Smither John WChief Financial OfficerMar 10, 2021 Option Exercise$1.6850084046,821Mar 11, 2021, 03:59 PM
Smither John WChief Financial OfficerMar 10, 2021 Sale$32.901,25041,12586,715Mar 11, 2021, 03:59 PM
Smither John WChief Financial OfficerMar 10, 2021 Sale$32.9050016,45046,321Mar 11, 2021, 03:59 PM
Watanabe Todd FranklinPresident and CEOMar 05, 2021 Sale$30.551,75053,462597,166Mar 05, 2021, 03:56 PM
Smither John WChief Financial OfficerMar 04, 2021 Option Exercise$1.6812,39620,83346,321Mar 05, 2021, 03:55 PM
Watanabe Todd FranklinPresident and CEOMar 02, 2021 Sale$35.192,10774,136566,216Mar 03, 2021, 04:51 PM
OSBORNE DAVID WChief Technical OfficerMar 01, 2021 Sale$34.5778026,968237,253Mar 03, 2021, 04:50 PM
Turney Patricia A.SVP, OperationsMar 01, 2021 Sale$34.5293432,2429,271Mar 03, 2021, 04:49 PM
Smither John WChief Financial OfficerMar 01, 2021 Sale$34.2077326,44024,425Mar 03, 2021, 04:48 PM
Lock Kenneth A.Chief Commercial OfficerMar 01, 2021 Sale$34.2093331,90822,167Mar 03, 2021, 04:47 PM
Welgus Howard G.DirectorMar 01, 2021 Option Exercise$3.922,2008,626207,833Mar 03, 2021, 12:00 AM
Welgus Howard G.DirectorMar 01, 2021 Sale$34.372,20075,610205,799Mar 03, 2021, 12:00 AM
CHAUDHURI BHASKARDirectorFeb 22, 2021 Sale$35.5210,000355,191884,180Feb 24, 2021, 03:33 PM
Welgus Howard G.DirectorFeb 16, 2021 Option Exercise$1.172,6543,116205,633Feb 17, 2021, 08:35 PM
Smither John WChief Financial OfficerFeb 10, 2021 Option Exercise$1.687501,26025,948Feb 12, 2021, 05:32 PM
Smither John WChief Financial OfficerFeb 10, 2021 Sale$35.642,00071,28087,965Feb 12, 2021, 05:32 PM
Smither John WChief Financial OfficerFeb 10, 2021 Sale$35.6475026,73025,198Feb 12, 2021, 05:32 PM
Watanabe Todd FranklinPresident and CEOFeb 05, 2021 Option Exercise$1.6810,00016,806578,323Feb 08, 2021, 04:00 PM
Watanabe Todd FranklinPresident and CEOFeb 05, 2021 Sale$34.2910,000342,916575,023Feb 08, 2021, 04:00 PM
Welgus Howard G.DirectorFeb 04, 2021 Option Exercise$1.6819,86133,378202,979Feb 08, 2021, 01:45 PM
Welgus Howard G.DirectorFeb 01, 2021 Option Exercise$1.682,2003,697185,318Feb 03, 2021, 11:24 AM
Welgus Howard G.DirectorFeb 01, 2021 Sale$34.352,20075,572184,768Feb 03, 2021, 11:24 AM
Smither John WChief Financial OfficerFeb 01, 2021 Option Exercise$1.681,2502,10126,448Feb 03, 2021, 11:23 AM
Smither John WChief Financial OfficerFeb 01, 2021 Sale$35.003,750131,25089,965Feb 03, 2021, 11:23 AM
Smither John WChief Financial OfficerFeb 01, 2021 Sale$35.001,25043,75025,198Feb 03, 2021, 11:23 AM
CHAUDHURI BHASKARDirectorFeb 01, 2021 Sale$33.259,949330,804891,391Feb 02, 2021, 07:39 PM
CHAUDHURI BHASKARDirectorJan 29, 2021 Sale$27.50511,403901,340Feb 02, 2021, 07:39 PM
Smither John WChief Financial OfficerJan 19, 2021 Option Exercise$1.6850084025,698Jan 21, 2021, 04:41 PM
Smither John WChief Financial OfficerJan 19, 2021 Sale$30.001,25037,50093,715Jan 21, 2021, 04:41 PM
Smither John WChief Financial OfficerJan 19, 2021 Sale$30.0050015,00025,198Jan 21, 2021, 04:41 PM
Welgus Howard G.DirectorJan 12, 2021 Option Exercise$0.581,222709183,118Jan 14, 2021, 11:11 AM
Watanabe Todd FranklinPresident and CEOJan 05, 2021 Option Exercise$1.6810,00016,806578,323Jan 07, 2021, 03:13 PM
Watanabe Todd FranklinPresident and CEOJan 05, 2021 Sale$28.0810,000280,754568,323Jan 07, 2021, 03:13 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Option Exercise$1.683,0005,042569,928Jan 07, 2021, 02:39 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Sale$30.003,00090,000566,928Jan 07, 2021, 02:39 PM
Welgus Howard G.DirectorJan 04, 2021 Option Exercise$1.682,2003,697184,096Jan 06, 2021, 01:16 PM
Welgus Howard G.DirectorJan 04, 2021 Sale$27.822,20061,215181,896Jan 06, 2021, 01:16 PM
OSBORNE DAVID WChief Technical OfficerDec 14, 2020 Sale$30.0015,000450,000250,533Dec 16, 2020, 03:15 PM
Smither John WChief Financial OfficerDec 14, 2020 Option Exercise$1.681,5002,52126,698Dec 16, 2020, 03:14 PM
Smither John WChief Financial OfficerDec 14, 2020 Sale$30.003,750112,50094,965Dec 16, 2020, 03:14 PM
Smither John WChief Financial OfficerDec 14, 2020 Sale$30.001,50045,00025,198Dec 16, 2020, 03:14 PM
Welgus Howard G.DirectorDec 14, 2020 Option Exercise$0.581,222709181,896Dec 16, 2020, 03:14 PM
Welgus Howard G.DirectorDec 01, 2020 Option Exercise$1.682,2003,696182,044Dec 03, 2020, 07:40 PM
Welgus Howard G.DirectorDec 01, 2020 Sale$25.982,20057,155181,157Dec 03, 2020, 07:40 PM
Welgus Howard G.DirectorNov 12, 2020 Option Exercise$0.581,222709179,844Nov 13, 2020, 11:57 AM
Welgus Howard G.DirectorNov 02, 2020 Option Exercise$1.682,2003,696180,822Nov 04, 2020, 04:33 PM
Welgus Howard G.DirectorNov 02, 2020 Sale$18.272,20040,186178,622Nov 04, 2020, 04:33 PM
Lock Kenneth A.Chief Commercial OfficerOct 26, 2020 Option Exercise$6.522,66817,39521,863Oct 27, 2020, 02:03 PM
Lock Kenneth A.Chief Commercial OfficerOct 22, 2020 Option Exercise$6.522,69517,57119,195Oct 23, 2020, 01:27 PM
Lock Kenneth A.Chief Commercial OfficerOct 15, 2020 Option Exercise$6.527,50048,90016,500Oct 16, 2020, 02:06 PM
Welgus Howard G.DirectorOct 15, 2020 Option Exercise$0.581,222709178,622Oct 16, 2020, 02:06 PM
ORBIMED ADVISORS LLCDirectorOct 02, 2020 Buy$25.00496,00012,400,0004,267,564Oct 06, 2020, 05:27 PM
SILVERSTEIN JONATHANDirectorOct 02, 2020 Buy$25.00496,00012,400,0004,267,564Oct 06, 2020, 05:23 PM
Welgus Howard G.DirectorOct 01, 2020 Option Exercise$1.682,2003,696179,210Oct 05, 2020, 09:13 PM
Welgus Howard G.DirectorOct 01, 2020 Sale$27.652,20060,829177,400Oct 05, 2020, 09:13 PM
Welgus Howard G.DirectorSep 01, 2020 Option Exercise$1.682,2003,696177,350Oct 05, 2020, 09:12 PM
Welgus Howard G.DirectorSep 01, 2020 Sale$24.382,20053,643176,178Oct 05, 2020, 09:12 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Option Exercise$1.683,0005,042569,928Oct 01, 2020, 09:02 PM
Watanabe Todd FranklinPresident and CEOSep 29, 2020 Sale$30.003,00090,000566,928Oct 01, 2020, 09:02 PM
OSBORNE DAVID WChief Technical OfficerSep 29, 2020 Sale$30.0015,000450,000264,279Oct 01, 2020, 09:01 PM
Smither John WChief Financial OfficerSep 29, 2020 Option Exercise$1.6850084024,375Oct 01, 2020, 09:00 PM
Smither John WChief Financial OfficerSep 29, 2020 Sale$30.001,25037,50098,715Oct 01, 2020, 09:00 PM
Smither John WChief Financial OfficerSep 29, 2020 Sale$30.0050015,00023,875Oct 01, 2020, 09:00 PM
Welgus Howard G.DirectorSep 15, 2020 Option Exercise$0.581,222709177,400Sep 16, 2020, 05:57 PM
Welgus Howard G.DirectorSep 01, 2020 Option Exercise$1.682,2003,696178,378Sep 02, 2020, 11:48 AM
Welgus Howard G.DirectorSep 01, 2020 Sale$24.382,20053,643176,178Sep 02, 2020, 11:48 AM
Welgus Howard G.DirectorAug 20, 2020 Option Exercise$1.685,0008,400176,178Aug 21, 2020, 02:19 PM
Welgus Howard G.DirectorAug 18, 2020 Option Exercise$1.685,0768,528171,178Aug 19, 2020, 05:48 PM
Welgus Howard G.DirectorAug 14, 2020 Option Exercise$0.586,1103,545166,102Aug 18, 2020, 04:12 PM
Welgus Howard G.DirectorAug 03, 2020 Option Exercise$1.682,8004,704162,725Aug 05, 2020, 05:11 PM
Welgus Howard G.DirectorAug 03, 2020 Sale$25.632,80071,764159,992Aug 05, 2020, 05:11 PM
Smither John WChief Financial OfficerJun 11, 2020 Option Exercise$1.6814,87524,999123,840Jun 15, 2020, 03:15 PM
Watanabe Todd FranklinPresident and CEOMar 13, 2020 Option Exercise$1.6859,48199,964566,928Mar 16, 2020, 06:05 PM
Welgus Howard G.Chief Medical OfficerMar 12, 2020 Option Exercise$0.586,1103,545159,992Mar 16, 2020, 06:04 PM
Bain Capital Life Sciences Investors, LLC10% OwnerFeb 04, 2020 Buy$17.00294,1174,999,9893,979,292Feb 06, 2020, 04:26 PM
Heron Patrick JDirectorFeb 04, 2020 Buy$17.00500,0008,500,00010,542,790Feb 06, 2020, 11:27 AM
Frazier Life Sciences VIII, L.P.10% OwnerFeb 04, 2020 Buy$17.00500,0008,500,00010,542,790Feb 06, 2020, 10:29 AM
ORBIMED ADVISORS LLCDirectorFeb 03, 2020 Buy$17.00558,8889,501,096382,388Feb 04, 2020, 05:30 PM
SILVERSTEIN JONATHANDirectorFeb 03, 2020 Buy$17.00558,8889,501,096382,388Feb 04, 2020, 05:27 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Welgus Howard G.Director06/04/202416,806
Welgus Howard G.Director06/04/202480,092
Burnett PatrickSee Remarks05/30/2024201,319
Burnett PatrickSee Remarks05/29/2024435,387
Matsuda MasaruSee Remark05/28/202415,988
Edwards Larry ToddSVP Chief Commercial Officer05/17/202468,582
Moore Matthew RichardSVP and Chief Business Officer05/02/202440,902
Watanabe Todd FranklinSee Remarks05/02/2024120,433
Matsuda MasaruSee Remark05/02/202443,829
Burnett PatrickSee Remarks05/02/202483,490
Matsuda MasaruSee Remark03/04/202441,816
Burnett PatrickSee Remarks03/04/202453,182
Watanabe Todd FranklinSee Remarks03/04/2024165,739
Moore Matthew RichardSVP and Chief Business Officer03/04/202438,568
Heron Patrick JDirector03/04/2024199,994
Burnett PatrickSee Remarks01/02/20244,692
Watanabe Todd FranklinSee Remarks12/01/2023100,038
Watanabe Todd FranklinSee Remarks05/31/20239,334
Matsuda MasaruSee Remark11/21/20233,661
Frazier Life Sciences VIII, L.P.10% Owner10/24/2023200,000
Burnett PatrickSee Remarks08/21/202311,302
Matsuda MasaruSee Remark05/31/20239,334
Matsuda MasaruSee Remark05/31/202314,278
Welgus Howard G.Director04/17/202314,285
Welgus Howard G.Director04/17/2023118,728
Welgus Howard G.Director04/06/202314,285
Welgus Howard G.Director04/06/2023102,085
Watanabe Todd FranklinSee Remarks03/06/202337,167
Burrows Scott LChief Financial Officer03/06/20234,442
Burnett PatrickSee Remarks03/06/202312,989
Turney Patricia A.SVP, Operations03/06/202312,684
OSBORNE DAVID WChief Technical Officer03/06/202310,532
Lock Kenneth A.Chief Commercial Officer03/06/202312,684
Moore Matthew RichardSee Remarks03/02/202325,481
Matsuda MasaruSee Remarks03/02/202322,696
Burnett PatrickSee Remarks03/02/202327,713
Turney Patricia A.SVP, Operations02/28/202315,132
Turney Patricia A.SVP, Operations03/02/202322,664
Watanabe Todd FranklinSee Remarks03/02/202386,606
Watanabe Todd FranklinSee Remarks02/28/202337,878
Burrows Scott LChief Financial Officer03/02/202322,696
Burrows Scott LChief Financial Officer02/28/20236,725
Lock Kenneth A.Chief Commercial Officer03/02/202322,664
Lock Kenneth A.Chief Commercial Officer02/28/202315,132
OSBORNE DAVID WChief Technical Officer03/02/202319,198
OSBORNE DAVID WChief Technical Officer02/28/202312,804
Welgus Howard G.Director02/15/202314,285
Welgus Howard G.Director02/15/2023144,352
Watanabe Todd FranklinSee Remarks02/14/20238,800
Watanabe Todd FranklinSee Remarks02/13/20238,211
Watanabe Todd FranklinSee Remarks02/01/202317,003
Welgus Howard G.Director01/17/202314,280
Welgus Howard G.Director01/17/2023116,655
Burnett PatrickSee Remarks01/03/202322,136
Watanabe Todd FranklinSee Remarks12/07/202217,060
Matsuda MasaruSee Remark11/21/202231,289
Welgus Howard G.Director11/15/20221,714
Welgus Howard G.Director11/15/202268,103
Watanabe Todd FranklinSee Remarks11/07/202218,004
Watanabe Todd FranklinPresident and CEO10/07/202219,510
Welgus Howard G.Director10/04/2022121,766
Burrows Scott LChief Financial Officer09/16/20228,403
Watanabe Todd FranklinPresident and CEO09/07/202221,510
Welgus Howard G.Director08/15/2022148,789
Watanabe Todd FranklinPresident and CEO08/05/20224,202
Watanabe Todd FranklinPresident and CEO08/05/202261,858
Frazier Life Sciences VIII, L.P.10% Owner08/05/20225,000,000
Turney Patricia A.SVP, Operations03/23/202299,958
Welgus Howard G.Director07/18/2022146,374
OSBORNE DAVID WChief Technical Officer07/08/202255,835
Watanabe Todd FranklinPresident and CEO07/08/202211,910
Watanabe Todd FranklinPresident and CEO07/08/2022342,473
Watanabe Todd FranklinPresident and CEO07/06/202222,070
ORBIMED ADVISORS LLC10% Owner06/24/20227,287,402
Watanabe Todd FranklinPresident and CEO06/06/202221,064
Matsuda MasaruSVP and General Counsel06/02/202235,419
Welgus Howard G.Director06/01/20224,202
Welgus Howard G.Director06/01/202251,539
Watanabe Todd FranklinPresident and CEO05/05/202221,760
Welgus Howard G.Director05/02/20222,555
Welgus Howard G.Director05/02/202251,112
OSBORNE DAVID WChief Technical Officer04/21/202244,872
ORBIMED ADVISORS LLC10% Owner04/07/20227,127,617
ORBIMED ADVISORS LLC10% Owner04/06/20226,893,991
ORBIMED ADVISORS LLC10% Owner04/08/20224,142,000
Watanabe Todd FranklinPresident and CEO04/05/202221,430
Welgus Howard G.Director04/01/20224,352
Welgus Howard G.Director04/01/2022150,184
Turney Patricia A.SVP, Operations03/23/2022165,139
Turney Patricia A.SVP, Operations03/23/2022165,139
Watanabe Todd FranklinPresident and CEO03/09/20225,100
Watanabe Todd FranklinPresident and CEO03/07/20221,176
Watanabe Todd FranklinPresident and CEO03/07/202213,125
Watanabe Todd FranklinPresident and CEO03/04/202241,962
Burnett PatrickSee Remarks03/04/202216,539
Burnett PatrickSee Remarks03/07/2022493
Lock Kenneth A.Chief Commercial Officer03/07/2022493
Lock Kenneth A.Chief Commercial Officer03/04/202216,741
Burrows Scott LChief Financial Officer03/07/2022164
Burrows Scott LChief Financial Officer03/04/20224,940
Turney Patricia A.SVP, Operations03/07/2022493
Turney Patricia A.SVP, Operations03/04/202216,741
OSBORNE DAVID WChief Technical Officer03/07/2022460
OSBORNE DAVID WChief Technical Officer03/04/202213,959
Watanabe Todd FranklinPresident and CEO03/01/202238,222
Lock Kenneth A.Chief Commercial Officer03/01/202216,599
Watanabe Todd FranklinPresident and CEO02/09/20221,681
Watanabe Todd FranklinPresident and CEO02/09/202217,000
Watanabe Todd FranklinPresident and CEO01/05/20221,681
Watanabe Todd FranklinPresident and CEO01/05/202221,592
Welgus Howard G.Director01/03/20221,451
Welgus Howard G.Director01/03/202253,029
Burrows Scott LChief Financial Officer12/27/2021252,139
Welgus Howard G.Director12/23/20211,451
Welgus Howard G.Director12/23/202150,395
Watanabe Todd FranklinPresident and CEO12/08/20211,681
Watanabe Todd FranklinPresident and CEO12/08/202117,000
Watanabe Todd FranklinPresident and CEO11/05/20211,681
Watanabe Todd FranklinPresident and CEO11/05/202121,502
Welgus Howard G.Director11/01/20211,451
Welgus Howard G.Director11/01/202154,524
Watanabe Todd FranklinPresident and CEO10/05/20214,202
Watanabe Todd FranklinPresident and CEO10/05/202162,294
Welgus Howard G.Director10/01/20211,451
Welgus Howard G.Director10/01/202159,680
Watanabe Todd FranklinPresident and CEO10/01/20212,521
Watanabe Todd FranklinPresident and CEO10/01/202137,510
Watanabe Todd FranklinPresident and CEO09/07/20211,681
Watanabe Todd FranklinPresident and CEO09/07/202121,137
Welgus Howard G.Director09/01/20217,791
Welgus Howard G.Director09/01/2021103,986
Watanabe Todd FranklinPresident and CEO08/05/20211,681
Watanabe Todd FranklinPresident and CEO08/05/202120,810
Watanabe Todd FranklinPresident and CEO07/06/20212,941
Watanabe Todd FranklinPresident and CEO07/06/202146,515
Welgus Howard G.Director07/01/20218,674
Welgus Howard G.Director07/01/202157,476
CHAUDHURI BHASKARDirector06/24/202120,048
CHAUDHURI BHASKARDirector06/25/2021185,763
CHAUDHURI BHASKARDirector06/21/202169,190
Watanabe Todd FranklinPresident and CEO06/07/20212,941
Watanabe Todd FranklinPresident and CEO06/07/202146,113
CHAUDHURI BHASKARDirector04/20/2021280,568
Watanabe Todd FranklinPresident and CEO05/05/20212,701
Watanabe Todd FranklinPresident and CEO05/05/202159,500
Welgus Howard G.Director05/03/20218,674
Welgus Howard G.Director05/03/202176,547
Watanabe Todd FranklinPresident and CEO04/30/202152,500
CHAUDHURI BHASKARDirector04/20/2021280,568
Welgus Howard G.Director04/16/20213,117
CHAUDHURI BHASKARDirector03/22/2021311,021
Welgus Howard G.Director03/16/20213,114
Smither John WChief Financial Officer03/10/2021840
Smither John WChief Financial Officer03/10/202141,125
Smither John WChief Financial Officer03/10/202116,450
Watanabe Todd FranklinPresident and CEO03/05/202153,462
Smither John WChief Financial Officer03/04/202120,833
Watanabe Todd FranklinPresident and CEO03/02/202174,136
OSBORNE DAVID WChief Technical Officer03/01/202126,968
Turney Patricia A.SVP, Operations03/01/202132,242
Smither John WChief Financial Officer03/01/202126,440
Lock Kenneth A.Chief Commercial Officer03/01/202131,908
Welgus Howard G.Director03/01/20218,626
Welgus Howard G.Director03/01/202175,610
CHAUDHURI BHASKARDirector02/22/2021355,191
Welgus Howard G.Director02/16/20213,116
Smither John WChief Financial Officer02/10/20211,260
Smither John WChief Financial Officer02/10/202171,280
Smither John WChief Financial Officer02/10/202126,730
Watanabe Todd FranklinPresident and CEO02/05/202116,806
Watanabe Todd FranklinPresident and CEO02/05/2021342,916
Welgus Howard G.Director02/04/202133,378
Welgus Howard G.Director02/01/20213,697
Welgus Howard G.Director02/01/202175,572
Smither John WChief Financial Officer02/01/20212,101
Smither John WChief Financial Officer02/01/2021131,250
Smither John WChief Financial Officer02/01/202143,750
CHAUDHURI BHASKARDirector02/01/2021330,804
CHAUDHURI BHASKARDirector01/29/20211,403
Smither John WChief Financial Officer01/19/2021840
Smither John WChief Financial Officer01/19/202137,500
Smither John WChief Financial Officer01/19/202115,000
Welgus Howard G.Director01/12/2021709
Watanabe Todd FranklinPresident and CEO01/05/202116,806
Watanabe Todd FranklinPresident and CEO01/05/2021280,754
Watanabe Todd FranklinPresident and CEO09/29/20205,042
Watanabe Todd FranklinPresident and CEO09/29/202090,000
Welgus Howard G.Director01/04/20213,697
Welgus Howard G.Director01/04/202161,215
OSBORNE DAVID WChief Technical Officer12/14/2020450,000
Smither John WChief Financial Officer12/14/20202,521
Smither John WChief Financial Officer12/14/2020112,500
Smither John WChief Financial Officer12/14/202045,000
Welgus Howard G.Director12/14/2020709
Welgus Howard G.Director12/01/20203,696
Welgus Howard G.Director12/01/202057,155
Welgus Howard G.Director11/12/2020709
Welgus Howard G.Director11/02/20203,696
Welgus Howard G.Director11/02/202040,186
Lock Kenneth A.Chief Commercial Officer10/26/202017,395
Lock Kenneth A.Chief Commercial Officer10/22/202017,571
Lock Kenneth A.Chief Commercial Officer10/15/202048,900
Welgus Howard G.Director10/15/2020709
ORBIMED ADVISORS LLCDirector10/02/202012,400,000
SILVERSTEIN JONATHANDirector10/02/202012,400,000
Welgus Howard G.Director10/01/20203,696
Welgus Howard G.Director10/01/202060,829
Welgus Howard G.Director09/01/20203,696
Welgus Howard G.Director09/01/202053,643
Watanabe Todd FranklinPresident and CEO09/29/20205,042
Watanabe Todd FranklinPresident and CEO09/29/202090,000
OSBORNE DAVID WChief Technical Officer09/29/2020450,000
Smither John WChief Financial Officer09/29/2020840
Smither John WChief Financial Officer09/29/202037,500
Smither John WChief Financial Officer09/29/202015,000
Welgus Howard G.Director09/15/2020709
Welgus Howard G.Director09/01/20203,696
Welgus Howard G.Director09/01/202053,643
Welgus Howard G.Director08/20/20208,400
Welgus Howard G.Director08/18/20208,528
Welgus Howard G.Director08/14/20203,545
Welgus Howard G.Director08/03/20204,704
Welgus Howard G.Director08/03/202071,764
Smither John WChief Financial Officer06/11/202024,999
Watanabe Todd FranklinPresident and CEO03/13/202099,964
Welgus Howard G.Chief Medical Officer03/12/20203,545
Bain Capital Life Sciences Investors, LLC10% Owner02/04/20204,999,989
Heron Patrick JDirector02/04/20208,500,000
Frazier Life Sciences VIII, L.P.10% Owner02/04/20208,500,000
ORBIMED ADVISORS LLCDirector02/03/20209,501,096
SILVERSTEIN JONATHANDirector02/03/20209,501,096
Load More Insider Transactions
FUNDS WITH A POSITION IN ARCUTIS BIOTHERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
SUVRETTA CAPITAL MANAGEMENT, LLC7,877,2972.9%-7.03%Growth At A Reasonable Price
BLACKROCK INC.6,658,7410.00154%12.54%Other
GEODE CAPITAL MANAGEMENT, LLC1,971,4330.00181%13.07%Other
FARALLON CAPITAL MANAGEMENT LLC1,780,0000.08%NewEvent Driven, Value
BALYASNY ASSET MANAGEMENT L.P.780,7800.01%NewEvent Driven
RENAISSANCE TECHNOLOGIES LLC395,1000.00198%ExitedOther
AQR CAPITAL MANAGEMENT LLC31,0990.00052%-89.24%Other
D. E. SHAW & CO., INC.216,8660.00184%NewOther
TUDOR INVESTMENT CORP ET AL204,7790.01%NewEvent Driven, Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)33,7140.00581%NewOther
BLACKSTONE INC.24,1440.00097%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ARCUTIS BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR ARCUTIS BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
12.28%
1Q
12/31/2023
06/30/2023
12.82%
2Q
12/31/2023
03/31/2023
13.30%
3Q
12/31/2023
12/31/2022
13.54%
4Q
12/31/2023
09/30/2022
21.39%
5Q
12/31/2023
06/30/2022
34.78%
6Q
12/31/2023
03/31/2022
37.20%
7Q
12/31/2023
12/31/2021
38.03%
8Q
12/31/2023
09/30/2021
38.34%
9Q
12/31/2023
06/30/2021
38.61%
10Q
12/31/2023
03/31/2021
46.58%
11Q
12/31/2023
09/30/2020
83.60%
13Q
12/31/2023
06/30/2020
84.39%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
12.28%
1Q
06/30/2023
12.82%
2Q
03/31/2023
13.30%
3Q
12/31/2022
13.54%
4Q
09/30/2022
21.39%
5Q
06/30/2022
34.78%
6Q
03/31/2022
37.20%
7Q
12/31/2021
38.03%
8Q
09/30/2021
38.34%
9Q
06/30/2021
38.61%
10Q
03/31/2021
46.58%
11Q
09/30/2020
83.60%
13Q
06/30/2020
84.39%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ARCUTIS BIOTHERAPEUTICS INC
LOADING...